
Figure 1.
Foetal main pulmonary artery Doppler flow-trace (Ultrasound using 1–5 MHz high resolution convex matric probe, Samsung Hera i10 premium).
Table 1.
Comparison of pulmonary artery Doppler parameters between cases and controls.
| Pulmonary artery Doppler parameters | CASES | CONTROL | P-VALUE | ||
|---|---|---|---|---|---|
| MEAN | SD | MEAN | SD | ||
| Acceleration time (AT) | 47.44 | 6.56 | 29.80 | 8.16 | t=8.210 |
| p<0.0001 | |||||
| Ejection time (ET) | 158.06 | 20.13 | 172.62 | 26.24 | t=2.148 |
| p=0.0371 | |||||
| Ratio of Acceleration and Ejection time (PATET) | 0.28 | 0.05 | 0.17 | 0.04 | t=8.251 |
| p=0.0001 | |||||
Table 2.
Pulmonary artery Doppler parameters according to severity of ICP.
| Mild | Moderate | Severe | ||
|---|---|---|---|---|
| AT | 46.88 ± 7.63 | 47.52 ± 4.69 | 50.33 ± 4.03 | F=5.238 |
| p=0.0063 | ||||
| ET | 160.79 ± 25.24 | 154.14 ± 9.78 | 171.33 ± 20.17 | F=9.890 |
| p<0.0001 | ||||
| PATET | 0.28 ± 0.06 | 0.28 ± 0.04 | 0.26 ± 0.02 | F=3.571 |
| p=0.0306 |
Table 3:
Maternal Parameters.
| IOL | CASES | CONTROL | p-VALUE | ||
|---|---|---|---|---|---|
| NO*α [n=45] | YES*β [n=5] | NO*α [n=45] | YES*β [n=5] | ||
| AT | 46.70±6.43 | 53.40±3.97 | 30.00±8.18 | 25.00±8.49 | p<0.0001*α |
| p<0.0001*β | |||||
| ET | 157.20±20.17 | 166.20±17.21 | 173.31±26.47 | 156.00±15.56 | p=0.0035*α |
| p=0.0014*β | |||||
| PATET | 0.28±0.05 | 0.28±0.04 | 0.17±0.04 | 0.16±0.04 | p<0.0001*α |
| p<0.0001*β | |||||
| Mode of Delivery | NVD*α | LSCS*β | NVD*α | LSCS*β | p-VALUE |
| AT | 47.86±5.96 | 47.11±6.87 | 28.31±6.79 | 31.42±8.99 | <0.0001*α |
| <0.0001*β | |||||
| ET | 157.20±15.5 | 158.68±2.76 | 174.65±29.16 | 170.42±21.81 | 0.0003*α |
| 0.0003*β | |||||
| PATET | 0.27±0.05 | 0.28±0.06 | 0.17±0.05 | 0.18±0.04 | <0.0001*α |
| <0.0001*β | |||||
| MSL | Yes*α | No*β | Yes*α | No*β | p-VALUE |
| AT | 48.93±7.61 | 48.51±5.62 | 31.56±7.21 | 29.41±8.20 | <0.0001*α |
| <0.0001*β | |||||
| ET | 163.60±27.67 | 155.59±14.85 | 178.44±22.26 | 171.34±26.55 | 0.0039*α |
| 0.0004*β | |||||
| PATET | 0.25±0.05 | 0.29±0.05 | 0.17±0.03 | 0.17±0.05 | <0.0001*α |
| <0.0001*β | |||||
| PROM | Yes*α | No*β | Yes*α | No*β | p-VALUE |
| AT | 49.50±1.50 | 47.35±6.61 | 26.80±5.81 | 30.13±8.22 | <0.0001*α |
| <0.0001*β | |||||
| ET | 138.50±6.50 | 158.88±19.88 | 175.20±21.30 | 172.33±26.4 | <0.0001*α |
| 0.0049*β | |||||
| PATET | 0.31±0.08 | 0.27±0.05 | 0.14±0.03 | 0.18±0.04 | <0.0001*α |
| <0.0001*β | |||||

Figure 2.
Graphical representations of ratio of AT and ET (PATET) as per gestational age (weeks) between cases and controls.
Table 4:
Incidence of respiratory distress syndrome (RDS) in neonates among cases and controls.
| RESPIRATORY DISTRESS SYNDROME | CASES | CONTROL | p-VALUE | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| No | 30 | 60.00% | 41 | 82.00% | X=5.877 |
| Yes | 20 | 40.00% | 9 | 18.00% | p=0.0153* |
Table 5:
Neonatal Parameters.
| Birth Weight | CASES | CONTROL | p-VALUE | ||
|---|---|---|---|---|---|
| <2500gm*α | ≥2500gm*β | <2500gm*α | ≥2500gm*β | ||
| AT | 48.86±5.05 | 47.21±6.67 | 27.89±6.71 | 30.22±8.29 | <0.0001*α |
| <0.0001*β | |||||
| ET | 152.86±7.85 | 158.91±21.14 | 190.33±41.47 | 168.73±9.01 | <0.0001α |
| 0.0032β | |||||
| PATET | 0.28±0.05 | 0.28±0.05 | 0.15±0.03 | 0.18±0.04 | <0.0001*α |
| <0.0001*β | |||||
| Apgar Score (5 Min) | 4–7*α | 8–10*β | 4–7*α | 8–10*β | p-VALUE |
| AT | 44.00±0.00 | 47.51±6.54 | 29.33±7.93 | 29.83±8.09 | <0.0001*α |
| <0.0001*β | |||||
| ET | 152.00±0.00 | 158.18±20.11 | 178.00±14.24 | 172.28±26.51 | <0.0001*α |
| 0.0035*β | |||||
| PATET | 0.23±0.00 | 0.28±0.05 | 0.17±0.06 | 0.17±0.04 | <0.0001*α |
| <0.0001*β | |||||
| NICU ADMISSION | Yes*α | No*β | Yes*α | No*β | p-VALUE |
| AT | 46.74±7.55 | 48.04±5.36 | 31.92±7.66 | 29.13±8.09 | <0.0001*α |
| <0.0001*β | |||||
| ET | 165.35±24.16 | 151.85±12.44 | 174.50±24.31 | 172.03±26.46 | 0.0620*α |
| <0.0001*β | |||||
| PATET | 0.26±0.05 | 0.29±0.05 | 0.19±0.04 | 0.17±0.04 | <0.0001*α |
| <0.0001*β | |||||
| RDS | Yes*α | No*β | Yes*α | No*β | p-VALUE |
| AT | 47.50±7.66 | 47.40±5.58 | 32.89±8.23 | 29.12±7.88 | <0.0001*α |
| <0.0001*β | |||||
| ET | 161.85±13.13 | 155.53±23.05 | 182.11±22.56 | 170.54±26.21 | <0.0001*α |
| 0.0030*β | |||||
| PATET | 0.27±0.05 | 0.28±0.05 | 0.19±0.05 | 0.17±0.04 | <0.0001*α |
| <0.0001*β | |||||

Figure 3.
Correlation Matrix in ICP-affected pregnancies.